Corcept Therapeutics (CORT) Tops Q1 EPS by 1c

Go back to Corcept Therapeutics (CORT) Tops Q1 EPS by 1c

Corcept Therapeutics Announces First Quarter 2016 Financial Results and Provides Corporate Update

May 3, 2016 4:06 PM EDT

MENLO PARK, CA -- (Marketwired) -- 05/03/16 -- Corcept Therapeutics Incorporated (NASDAQ: CORT)

First quarter revenue of $16.1 million, a 59 percent increase from the first quarter of 2015 Excluding non-cash expenses, first quarter non-GAAP net income of $0.02 per share, compared to a non-GAAP net loss of $0.03 per share in the first quarter of 2015 GAAP breakeven in the first quarter of 2016, compared to a GAAP net loss of $0.05 per share in the first quarter of 2015 Cash balance at March 31 increases to $40.7 million Company reiterates 2016 revenue guidance of $76-81 million Results... More

Corcept Therapeutics to Announce First Quarter Financial Results and Corporate Update and Host Conference Call

April 29, 2016 8:30 AM EDT

MENLO PARK, CA -- (Marketwired) -- 04/29/16 -- Corcept Therapeutics Incorporated (NASDAQ: CORT) today announced it will report first quarter financial results and provide a corporate update on May 3, 2016. The Company will also host a conference call that day at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time).

Conference Call... More